NTUH GLP-1 Drug Study Points to Drop in Obesity-Linked Cancer Risk
Taipei: Weight-loss injections based on GLP-1 receptor agonists were associated with a 41 percent lower risk of developing 13 obesity-related cancers than weight loss achieved through diet and exercise alone, according to a National Taiwan University …